Pfizer Inc. is threatening legal action at an attempt by Novo Nordisk A/S to scupper its acquisition of Metsera Inc., with an unsolicited $9 billion offer for the anti-obesity specialist. That trumps ...

Two in five preclinical studies on subarachnoid hemorrhage (SAH) published in peer-reviewed scientific journals contain ...

Medline Inc. filed a public S1 with the SEC Oct. 28, moving the IPO first signaled in December 2024 closer to reality. The Northfield, Ill.-based medical supply distributor did not disclose the number ...

Only two days after Bridgebio Pharma Inc. impressed investors with data from BBP-418 in limb-girdle muscular dystrophy type ...

Restrictive element-1 silencing transcription factor (REST) has key roles in neuronal differentiation, structural remodeling and plasticity, contributing to... Copyright ©2025. All Rights Reserved.

Leading advances in cancer research, the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer ...

With a modest $7 million up front but an ultimate payout potentially topping $1 billion on the line, Modex Therapeutics Inc.

Shooting for further proof of durable, drug-free, disease-free remission with a single dose of KYV-101 in generalized ...

Australian scientists have developed a simpler, less invasive way to detect Alzheimer’s disease that could make it easier for ...

CDR-609 is a T-cell engager therapeutic from CDR-Life Inc. that targets Leucine-rich repeat-containing G protein-coupled ...

Zag Bio Inc. came out of stealth mode with $80 million in funding so far, including a recently closed series A financing, to ...

The DeGregorio Family Foundation, with support from the Esophageal Cancer Awareness Association, has awarded an additional ...